SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-20-009547
Filing Date
2020-06-16
Accepted
2020-06-16 16:47:40
Documents
1
Period of Report
2020-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_159234044255883.html 4  
1 FORM 4 wf-form4_159234044255883.xml 4 3873
  Complete submission text file 0001628280-20-009547.txt   5399
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INCYTE CORPORATION, EXPERIMENTAL STN ROUTE 141 & HENRY CLAY ROAD, BLDG. E336 WILMINGTON DE 19880
Business Address
Huber Reid M (Reporting) CIK: 0001607052 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36783 | Film No.: 20966966